UROGEN PHARMA LTD's ticker is and the CUSIP is M96088955. A total of 2 filers reported holding UROGEN PHARMA LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,629 | -95.2% | 2,900 | -94.2% | 0.00% | -100.0% |
Q3 2021 | $841,000 | +10.1% | 50,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $764,000 | -53.8% | 50,000 | -41.1% | 0.00% | -50.0% |
Q1 2021 | $1,654,000 | -61.7% | 84,900 | -64.6% | 0.00% | -71.4% |
Q4 2020 | $4,323,000 | +11.9% | 239,900 | +19.8% | 0.01% | -41.7% |
Q3 2020 | $3,864,000 | +5.7% | 200,300 | +43.1% | 0.01% | -29.4% |
Q2 2020 | $3,657,000 | +513.6% | 140,000 | +319.2% | 0.02% | +240.0% |
Q1 2020 | $596,000 | -69.4% | 33,400 | -42.8% | 0.01% | -61.5% |
Q4 2019 | $1,949,000 | +38880.0% | 58,400 | +58300.0% | 0.01% | – |
Q3 2018 | $5,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 140,000 | $3,657,000 | 0.02% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |